NCT07484022 2026-03-19Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial CancerGenerate BiomedicinesPhase 1 Not yet recruiting37 enrolled
NCT07481149 2026-03-18EX-CIPNUniversity Health Network, TorontoPhase 3 Not yet recruiting240 enrolled